Patents by Inventor Gabriele Ugolini

Gabriele Ugolini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecules that are able to inhibit the binding between NGF and the TrkA receptor as analgesics with prolonged effect
    Patent number: 9688749
    Abstract: Use of an anti-NGF antibody capable of inhibiting the binding between NGF and TrkA, capable of blocking the biological activity of TrkA for the preparation of a medicament for treating and/or preventing chronic pain.
    Type: Grant
    Filed: June 7, 2006
    Date of Patent: June 27, 2017
    Assignee: AbbVie Inc.
    Inventors: Flaminia Pavone, Sara Martinelli, Antonino Cattaneo, Gabriele Ugolini
  • ANTI-TRKA ANTIBODIES, DERIVATIVES AND USES THEREOF
    Publication number: 20160244529
    Abstract: The present invention relates to an antibody, recombinant or synthetic antigen-binding fragments thereof able to recognise and bind an epitope comprised in the TrkA amino acid sequence, medical uses thereof and a pharmaceutical composition comprising at least one of the above antibody, recombinant or synthetic antigen-binding fragments thereof.
    Type: Application
    Filed: May 12, 2016
    Publication date: August 25, 2016
    Inventors: Lucio Claudio ROVATI, Michela VISINTIN, Gianfranco CASELLI, Gabriele UGOLINI
  • Anti-TrkA antibodies, derivatives and uses thereof
    Patent number: 9365654
    Abstract: The present invention relates to an antibody, recombinant or synthetic antigen-binding fragments thereof able to recognize and bind an epitope comprised in the TrkA amino acid sequence, medical uses thereof and a pharmaceutical composition comprising at least one of the above antibody, recombinant or synthetic antigen-binding fragments thereof.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: June 14, 2016
    Assignee: ROTTAPHARM BIOTECH S.R.L.
    Inventors: Lucio Claudio Rovati, Michela Visintin, Gianfranco Caselli, Gabriele Ugolini
  • Method for the potentiation of opioid analgesics effects on pain
    Patent number: 8715666
    Abstract: According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.
    Type: Grant
    Filed: June 23, 2011
    Date of Patent: May 6, 2014
    Assignee: Lay Line Genomics S.p.A.
    Inventors: Flaminia Pavone, Sara Marinelli, Antonio Cattaneo, Gabriele Ugolini
  • Analgesic treatment with prolonged effect
    Patent number: 8691221
    Abstract: Use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA, in particular capable of blocking the biological activity of TrkA, for the preparation of a medicament for treating and/or preventing chronic pain.
    Type: Grant
    Filed: June 7, 2006
    Date of Patent: April 8, 2014
    Assignee: Lay Line Genomics S.p.A.
    Inventors: Flaminia Pavone, Sara Marinelli, Antonio Cattaneo, Gabriele Ugolini
  • ANTI-TRKA ANTIBODIES, DERIVATIVES AND USES THEREOF
    Publication number: 20130336964
    Abstract: The present invention relates to an antibody, recombinant or synthetic antigen-binding fragments thereof able to recognise and bind an epitope comprised in the TrkA amino acid sequence, medical uses thereof and a pharmaceutical composition comprising at least one of the above antibody, recombinant or synthetic antigen-binding fragments thereof.
    Type: Application
    Filed: May 15, 2013
    Publication date: December 19, 2013
    Applicant: Rottapharm Biotech S.r.l.
    Inventors: Lucio Claudio ROVATI, Michela VISINTIN, Gianfranco CASELLI, Gabriele UGOLINI
  • METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN
    Publication number: 20120213784
    Abstract: According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.
    Type: Application
    Filed: June 23, 2011
    Publication date: August 23, 2012
    Applicant: LAY LINE GENOMICS S.p.A.
    Inventors: FLAMINIA PAVONE, SARA MARINELLI, ANTONIO CATTANEO, GABRIELE UGOLINI
  • Method for the potentiation of opioid analgesics effects on pain
    Patent number: 7988966
    Abstract: According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.
    Type: Grant
    Filed: June 23, 2006
    Date of Patent: August 2, 2011
    Assignee: Lay Line Genomics S.p.A.
    Inventors: Flaminia Pavone, Sara Marinelli, Antonino Cattaneo, Gabriele Ugolini
  • Novel Analgesic Treatment with Prolonged Effect
    Publication number: 20100291083
    Abstract: Use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA, in particular capable of blocking the biological activity of TrkA, for the preparation of a medicament for treating and/or preventing chronic pain.
    Type: Application
    Filed: June 7, 2006
    Publication date: November 18, 2010
    Applicant: NOVARTIS VACCINES AND DIAGONOSTICS
    Inventors: Flaminia Pavone, Sara Marinelli, Antonio Cattaneo, Gabriele Ugolini
  • Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect
    Publication number: 20090208490
    Abstract: Use of an anti-NGF antibody capable of inhibiting the binding between NGF and TrkA, capable of blocking the biological activity of TrkA for the preparation of a medicament for treating and/or preventing chronic pain.
    Type: Application
    Filed: June 7, 2006
    Publication date: August 20, 2009
    Inventors: Flaminia Pavone, Sara Martinelli, Antonino Cattaneo, Gabriele Ugolini
  • Method for the potentiation of opioid analgesics effects on pain
    Publication number: 20090123464
    Abstract: According to the invention there is provided use of an anti-TrkA antibody capable of inhibiting the binding between NGF and TrkA combined with at least one opioid analgesic for the preparation of a medicament for treating and/or preventing pain.
    Type: Application
    Filed: June 23, 2006
    Publication date: May 14, 2009
    Applicant: Lay Line Genomics S.p.A.
    Inventors: Flaminia Pavone, Sara Marinelli, Antonino Cattaneo, Gabriele Ugolini